Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
9.29
-0.11 (-1.17%)
Apr 16, 2026, 10:18 AM EDT - Market open

Kyverna Therapeutics Market Cap

Kyverna Therapeutics has a market cap or net worth of $561.63 million as of April 16, 2026. Its market cap has increased by 573.38% in one year.

Market Cap
561.63M
Enterprise Value
312.01M
1-Year Change
573.38%
Ranking
Category
Stock Price
$9.29

Market Cap Chart

Since the IPO on February 8, 2024, Kyverna Therapeutics's market cap has decreased from $898.10M to $561.63M, a decrease of -37.46%. That is a compound annual growth rate of -19.34%.

History

DateMarket Cap% Change
Apr 15, 2026568.28M5.82%
Dec 31, 2025537.02M232.60%
Dec 31, 2024161.46M-82.02%
Feb 8, 2024898.10M-

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

CompanyMarket Cap
Ocugen604.84M
Crescent Biopharma597.52M
ProKidney588.74M
MiMedx Group582.38M
CorMedix578.65M
Lyell Immunopharma578.54M
Zevra Therapeutics570.68M
Tectonic Therapeutic562.55M
Market Cap Rankings